ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2201

Self-Reported Breathlessness on Exertion Is Associated with Poor Outcomes Among Women with Systemic Lupus Erythematosus (SLE)

Patricia P. Katz1, Sofia Pedro2, Robert S. Katz3, Frederick Wolfe4 and Kaleb Michaud5, 1Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA, 2National Data Bank for Rheumatic Diseases, Wichita, KS, 3Rush University Medical Center, Chicago, IL, 4National Data Bank, Wichita, KS, 5University of Nebraska Medical Center, Omaha, NE

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: functional status, patient-reported outcome measures and systemic lupus erythematosus (SLE), Pulmonary Involvement

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 15, 2016

Title: Epidemiology and Public Health - ARHP Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:  Breathlessness is often considered as a predictor of functional outcomes in pulmonary disease, but has not been examined in SLE.

Methods:  Data were from the National Data Bank for Rheumatic Diseases (NDB), for which participants complete questionnaires every 6 months. Only women with SLE who completed one of the most recent completed questionnaires were included (n = 278). Breathlessness was assessed with the Medical Research Council questionnaire (Table 1). Outcomes examined were self-reported lupus status (Systemic Lupus Activity Questionnaire, SLAQ1), assessment of lupus activity (rating from 0 [not active] – 100 [very active]), global assessment of health status (rating from 0 [doing very well] – 10 [doing very poorly]), and self-reported assessments of pain, fatigue, and sleep problems, each rated 0 – 10 with higher ratings reflecting worse symptoms. ANOVAs and multivariate linear regression analyses estimated the relationship of breathlessness on outcomes. Multivariate analyses controlled for age, low education, low income, body mass index (BMI), duration of SLE, self-reported disease damage (Brief Inventory of Lupus Damage, BILD2), Rheumatic Disease Comorbidity Index (RDCI)3, current or former smoking, and self-reported chronic obstructive pulmonary disease (COPD) or asthma.

Results: Mean age was 58 ± 13 years, 22% had education ≤ high school, and 47% had low income. Mean disease duration was 21 ± 12 years, mean BMI was 29 ± 8, and mean score on the RDCI was 2.7 ± 1.8. 5% were current smokers, 41% were former smokers, and 7% had self-reported COPD. In both unadjusted and unadjusted analyses, breathlessness ratings were associated with worse outcomes on each measure (Table 2).

Conclusion: Breathlessness was associated with worse patient-reported outcomes among this group of women with SLE, even after controlling for disease status, smoking, and self-reported COPD. While self-reports of breathlessness are often used to assess pulmonary functioning, these items may also indicate poor cardiorespiratory fitness. 1 Karlson EW, et al. Lupus 2003; 12:280. 2 Yazdany J, et al. Arthritis Care Res 2011; 63:1170 3 England BR, et al. Arthritis Care Res 2015; 6: 865

Table 1. MRC categories and frequencies
% (n)
Group 0: Only get breathless with strenuous exercise 39.8 (98)
Group 1: Get short of breath when hurrying on a level or up a slight hill 25.6 (63)
Group 2: Walk slower than people of the same age on the level because of breathlessness or have to stop for breath when walking at my own pace on the level 14.2 (35)
Group 3: Have to stop for breath after walking 100 yards or after a few minutes on the level 20.2 (50)
Group 4: Too breathless to leave the house 0.8 (2)
• Groups 3 and 4 were combined for analysis. • Respondents were instructed not to answer items if activity problems were due to other physical problems
Table 2. Association of breathlessness ratings with outcomes
Group 0 Group 1 Group 2 Group 3/4 p-value*
SLAQ 8.3 ± 6.1 10.4 ± 6.3 13.5 ± 6.8 14.9 ± 7.8 .05
Lupus activity rating 21.1 ± 24.0 28.0 ± 22.9 38.1 ± 29.4 45.1 ± 30.6 .009
Global health status rating 2.5 ± 2.3 3.6 ± 2.3 4.9 ± 2.3 5.7 ± 2.7 <.0001
Pain 2.5 ± 2.6 4.0 ± 2.5 5.2 ± 2.8 5.5 ± 2.7 .005
Fatigue 3.5 ± 2.9 4.4 ± 2.7 6.4 ± 2.7 6.8 ± 2.5 <.0001
Sleep 3.1 ± 2.9 4.1 ± 3.0 5.3 ± 3.4 5.8 ± 3.0 .008
* p-value from multiple linear regression controlling for age, education, income, BMI, smoking (current or former), SLE duration, SLE damage (BILD score), comorbidity index (RDCI), and self-reported COPD (chronic obstructive pulmonary disease, emphysema, or chronic bronchitis) or asthma

Disclosure: P. P. Katz, None; S. Pedro, None; R. S. Katz, None; F. Wolfe, None; K. Michaud, Rheumatology Research Foundation, Pfizer, 2.

To cite this abstract in AMA style:

Katz PP, Pedro S, Katz RS, Wolfe F, Michaud K. Self-Reported Breathlessness on Exertion Is Associated with Poor Outcomes Among Women with Systemic Lupus Erythematosus (SLE) [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/self-reported-breathlessness-on-exertion-is-associated-with-poor-outcomes-among-women-with-systemic-lupus-erythematosus-sle/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/self-reported-breathlessness-on-exertion-is-associated-with-poor-outcomes-among-women-with-systemic-lupus-erythematosus-sle/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology